Chimerix to Present at 2019 Cantor Global Healthcare Conference
September 27 2019 - 8:00AM
Chimerix (NASDAQ:CMRX) today announced that Mike Sherman,
Chief Executive Officer, will present a corporate overview at the
upcoming 2019 Cantor Global Healthcare Conference on Thursday,
October 3, 2019 at 8:20 a.m. ET in New York
City.
A live audio webcast of the presentation will be available on
the Investor Relations section of Chimerix's website at
ir.chimerix.com, where it will be archived for approximately 90
days.
About Chimerix
Chimerix is a development-stage biopharmaceutical company
dedicated to accelerating the advancement of innovative medicines
that make a meaningful impact in the lives of patients living with
cancer and other serious diseases. Dociparstat sodium (CX-01) is an
investigational product targeting multiple proteins involved in
cancer cell resistance to chemotherapy under development for the
treatment of acute myeloid leukemia and other hematologic
malignancies. Brincidofovir (BCV, CMX001) is an anti-viral drug
candidate in development as a medical countermeasure for smallpox.
For further information, please visit the
Chimerix website, www.chimerix.com.
CONTACT:Investor
Relations:
Michelle LaSpaluto 919 972-7115 ir@chimerix.com Will O’Connor Stern
Investor Relations will@sternir.com 212-362-1200
Chimerix (NASDAQ:CMRX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Chimerix (NASDAQ:CMRX)
Historical Stock Chart
From Apr 2023 to Apr 2024